Doç. Dr. Deniz Işık

Prognostic scores in pulmonary large cell neuroendocrine carcinoma: A retrospective cohort study

Heliyon, 2024

DOI 10.1016/j.heliyon.2024.e25029 PMID 38317875 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

Efficacy and Safety of Ixabepilone in Metastatic Breast Cancer After Multiple Treatments: Analysis Based on Real-World Data

Journal of Oncological Sciences, 2024

DOI 10.37047/jos.2024-102164 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

The Clinical Significance of Fibrinogen-Like Protein 2 (FGL-2) Levels in Nonalcoholic Steatohepatitis

Southern Clinics of Istanbul Eurasia, 2024

DOI 10.14744/scie.2024.00187 Quelle: OpenAlex

Association of New Inflammatory Markers Cumulative Inflammatory Index (ICC) and Mean Corpuscular Volume/Lymphocyte (MCVL) with Anti PD-1 Antibody Nivolumab Treatment Response in Metastatic Renal Cell Carcinoma

Research Square, 2024

DOI 10.21203/rs.3.rs-5381728/v1 Frei zugänglicher VolltextQuelle: OpenAlex

Prognostic and Molecular Characterization of Metastatic Transverse Colon Cancer: Insights From a Single-Center Retrospective Study

Cureus, 2024

DOI 10.7759/cureus.75046 PMID 39629291 Frei zugänglicher VolltextQuelle: OpenAlex

Association of Hepatitis-B virus infection status with survival and treatment response in non-small cell lung cancer patients on anti‐pd‐1/pd-l1 therapy

Journal of Global Antimicrobial Resistance, 2024

DOI 10.1016/j.jgar.2024.10.248 Frei zugänglicher VolltextQuelle: OpenAlex

Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

BMC Cancer, 2023

DOI 10.1186/s12885-023-10609-8 PMID 36765293 18 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer

Future Oncology, 2023

DOI 10.2217/fon-2022-1287 PMID 37133230 22 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

Onkoloji

Akademisyen Kitabevi eBooks, 2022

DOI 10.37609/akya.1538 Frei zugänglicher VolltextQuelle: OpenAlex

Gastrointestinal Sistem Tümörleri-1

Akademisyen Kitabevi eBooks, 2022

DOI 10.37609/akya.1211 Frei zugänglicher VolltextQuelle: OpenAlex

Onkolojide Güncel Tedavi Yaklaşımları 1

Akademisyen Kitabevi eBooks, 2022

DOI 10.37609/akya.1606 Quelle: OpenAlex

Jinekolojik Tümörler

Akademisyen Kitabevi eBooks, 2022

DOI 10.37609/akya.1215 Quelle: OpenAlex

Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience

Cancer Investigation, 2021

DOI 10.1080/07357907.2021.1933011 PMID 34014777 10 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

Adjuvant Chemotherapy in Elderly Patients with Early-stage Non-small Cell Lung Cancer

Bezmialem Science, 2019

DOI 10.14235/bas.galenos.2018.2631 Frei zugänglicher VolltextQuelle: OpenAlex

Comparison of efficacy and safety of three different chemotherapy regimens delivered with concomitant radiotherapy in inoperable stage III non-small cell lung cancer patients

Tumor Biology, 2016

DOI 10.1007/s13277-015-4776-1 PMID 26753955 11 Zitationen (Europe PMC) Quelle: OpenAlex

Evaluation of Bevacizumab in Advanced Small Bowel Adenocarcinoma

Clinical Colorectal Cancer, 2016

DOI 10.1016/j.clcc.2016.04.013 PMID 27247089 17 Zitationen (Europe PMC) Quelle: OpenAlex

Three Different Chemotherapy Combinations with Concurrent Thoracic Radiation for Patients with Stage III Non-Small Cell Lung Cancer

Annals of Oncology, 2014

DOI 10.1093/annonc/mdu348.10 Frei zugänglicher VolltextQuelle: OpenAlex

Akdağ G, Doğan A, Yıldırım S, Işık D ve ark. Exploring the Clinical Impact of RANK Pathway Inhibition in Advanced Breast Cancer. Cureus, 2024.

Quelle: Profilseite auf emseyhospital.com.tr

Kahraman S, Hizal M, Işık D ve ark. Activity of CDK4/6 Inhibitors and Parameters Affecting Survival in Elderly Patients. BMC Cancer, 2024. (Q2)

Quelle: Profilseite auf emseyhospital.com.tr

Yıldırım S, Doğan A, Akdağ G, Işık D ve ark. Lymphocyte-to-Albumin Ratio Predicts Survival in Metastatic NSCLC Patients. Cancers, 2024. (Q1)

Quelle: Profilseite auf emseyhospital.com.tr

Akdağ G, Alan Ö, Doğan A, Işık D ve ark. Efficacy and Safety of Ixabepilone in Metastatic Breast Cancer After Multiple Treatments. Journal of Oncological Sciences, 2024.

Quelle: Profilseite auf emseyhospital.com.tr

Altıntaş YE, Kınıkoğlu O, Yıldız A, Işık D ve ark. Trastuzumab Rechallenge in HER2-Positive Metastatic Breast Cancer. Medicina, 2024. (Q1)

Quelle: Profilseite auf emseyhospital.com.tr

Yıldırım S, Alan Ö, Yüksel YZ, Işık D ve ark. Prognostic Impact and Clinical Features of Spread Through Air Spaces in Operated Lung Cancer. Medicina, 2024. (Q1)

Quelle: Profilseite auf emseyhospital.com.tr

Işık D, Kınıkoğlu O, Akdağ G ve ark. Clinical Effectiveness of Targeted Therapies Following Nivolumab Therapy in Metastatic Renal Cell Carcinoma. Medicina, 2024. (Q1)

Quelle: Profilseite auf emseyhospital.com.tr

Gürler F, Tay F, Işık D ve ark. Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma. Cancer Medicine, 2024. (Q2)

Quelle: Profilseite auf emseyhospital.com.tr

Akdağ G, Yıldırım S, Doğan A, Işık D ve ark. Neoadjuvant Chemotherapy and Pathologic Complete Response in HR+/HER2− Breast Cancer. Chemotherapy, 2024. (Q3)

Quelle: Profilseite auf emseyhospital.com.tr

Işık D, Koca D. XLOT Regimen Instead of FLOT Regimen in Gastric Cancer. Journal of Cancer Research and Therapeutics, 2023.

Quelle: Profilseite auf emseyhospital.com.tr

Kahraman S, Urul E, Işık D ve ark. Treatment Efficacy of Ribociclib or Palbociclib Plus Letrozole in Metastatic Breast Cancer. Future Oncology, 2023.

Quelle: Profilseite auf emseyhospital.com.tr

Karaçin C, Işık D ve ark. Efficacy of Subsequent Treatments in Patients with Hormone-Positive Advanced Breast Cancer. BMC Cancer, 2023.

Quelle: Profilseite auf emseyhospital.com.tr

Bahçeci A, Paydaş S, Işık D ve ark. Efficacy and Safety of Trastuzumab Emtansine in HER2 Positive Metastatic Breast Cancer. Cancer Investigation, 2021.

Quelle: Profilseite auf emseyhospital.com.tr

Bahçeci A, Kötek SA, Işık D. The Prognostic Values of Prognostic Nutritional Index in Extensive-Stage Small Cell Lung Cancer. Anti-Cancer Drugs, 2021.

Quelle: Profilseite auf emseyhospital.com.tr

Özçelik M, Korkmaz T, Odabaş H, Işık D ve ark. Comparison of Chemotherapy Regimens in Inoperable Stage III Non-Small Cell Lung Cancer. Tumor Biology, 2016.

Quelle: Profilseite auf emseyhospital.com.tr

Aydın D, Bilici A, Yavuzer D, Işık D ve ark. Prognostic Significance of ADAM17 Expression in Gastric Cancer. Clinical & Translational Oncology, 2015.

Quelle: Profilseite auf emseyhospital.com.tr

Özçelik M, Odabaş H, Işık D ve ark. Capecitabine Plus Bevacizumab Combination in Elderly Metastatic Colorectal Cancer Patients. Clinical & Translational Oncology, 2015.

Quelle: Profilseite auf emseyhospital.com.tr

Efficacy and Safety of CDK4/6 Inhibitor Therapy in Patients Aged 70 and Older with Metastatic Breast Cancer: A Retrospective Single Center Analysis. Southern Clinics of Istanbul Eurasia, 2025.

Quelle: Profilseite auf emseyhospital.com.tr

The Prevalence and Prognostic Relevance of ABO/Rh Blood Groups in Metastatic Breast Cancer Patients Undergoing CDK4/6 Inhibitor Therapy. Eurasian Journal of Medical Investigation, 2024.

Quelle: Profilseite auf emseyhospital.com.tr

Factors Affecting Recurrence in Transverse Colon Tumors: A Single-Center Study. Southern Clinics of Istanbul Eurasia, 2024.

Quelle: Profilseite auf emseyhospital.com.tr

Onkolojide Güncel Tedavi Yaklaşımları (2019) – Tiroid Kanserlerinde Tirozin Kinaz İnhibitör Tedavisi

Quelle: Profilseite auf emseyhospital.com.tr

Onkoloji (2018) – Jinekolojik Kanserler

Quelle: Profilseite auf emseyhospital.com.tr

Multidisipliner Baş Boyun Kanserleri Kongresi (2025)

Quelle: Profilseite auf emseyhospital.com.tr

Meme Kanseri Sempozyumu (2025)

Quelle: Profilseite auf emseyhospital.com.tr

Onkolojide Yenilikler Sempozyumu (2024)

Quelle: Profilseite auf emseyhospital.com.tr

Onkolojide Yenilikler Sempozyumu (2023)

Quelle: Profilseite auf emseyhospital.com.tr

Türk Tıbbi Onkoloji Kongresi (2023)

Quelle: Profilseite auf emseyhospital.com.tr